Randomized phase III Study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma : a GCIG and EORTC-GCG study

収録刊行物

• J Clin Oncol

  J Clin Oncol 30 LBA5000-, 2012